1. Song, Ying, Zhang, Weilong, He, Xue, Jing, Hongmei, Yuan, Xiaoliang. 2019. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia. In Journal of translational medicine, 17, 166. doi:10.1186/s12967-019-1904-5. https://pubmed.ncbi.nlm.nih.gov/31109331/
2. Luo, Dan, Liang, Yiran, Wang, Yajie, Jiang, Liyu, Yang, Qifeng. 2023. Long non-coding RNA MIDEAS-AS1 inhibits growth and metastasis of triple-negative breast cancer via transcriptionally activating NCALD. In Breast cancer research : BCR, 25, 109. doi:10.1186/s13058-023-01709-1. https://pubmed.ncbi.nlm.nih.gov/37770991/
3. Dong, Caihua, Yin, Fuqiang, Zhu, Dan, Chen, Cuilan, Liu, Xia. 2020. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer. In Journal of cellular biochemistry, 121, 4470-4483. doi:10.1002/jcb.29670. https://pubmed.ncbi.nlm.nih.gov/32030795/
4. Torres-Benito, Laura, Schneider, Svenja, Rombo, Roman, Bennett, C Frank, Wirth, Brunhilde. 2019. NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice. In American journal of human genetics, 105, 221-230. doi:10.1016/j.ajhg.2019.05.008. https://pubmed.ncbi.nlm.nih.gov/31230718/
5. Feng, Li-Yuan, Li, Li. 2020. Low expression of NCALD is associated with chemotherapy resistance and poor prognosis in epithelial ovarian cancer. In Journal of ovarian research, 13, 35. doi:10.1186/s13048-020-00635-6. https://pubmed.ncbi.nlm.nih.gov/32228639/
6. Zorkoltseva, Irina, Shadrina, Alexandra, Belonogova, Nadezhda, Tsepilov, Yakov, Axenovich, Tatiana. 2021. In silico genome-wide gene-based association analysis reveals new genes predisposing to coronary artery disease. In Clinical genetics, 101, 78-86. doi:10.1111/cge.14073. https://pubmed.ncbi.nlm.nih.gov/34687547/
智鼠故事 
